Panome Bio delivers 2.8X more actionable hits than the leading competition using a true untargeted metabolomics approach that matches all biologically-relevant hits to our 175,000 compound database of known metabolites.

Through leading-edge Metabolomics, Proteomics, and Multi-Omics Integration technologies, Panome Bio accelerates innovation within the life science community. We are committed to delivering unparalleled discovery potential, data quality, transparency, and customer experience, as our customers drive groundbreaking advancements in biotechnology ...

Panome Bio advances your research with Next-Generation Metabolomics. Our cutting-edge biomarker discovery pipeline allows complex experiments such as drug-target mapping, longitudinal studies, pathway analysis, and multi-omics.

Panome Bio can help you profile and discover biomarkers with our Next-Generation Metabolomics, lipidomics, proteomics, and integrated multi-omics capabilities, comprehensive workflows and...

2023年11月1日 · Panome Bio joins Seer’s global COE network of leading service providers, who are all committed to accelerating the adoption of unbiased, deep proteomics at scale. Seer COEs have been selected for their demonstrated expertise in proteomics, their ability to deliver the highest quality service, and their commitment to partnering to expand the ...

Panome Bio is a biomarker discovery platform offering biomarker analysis. The company's services also include metabolomics, lipidomics, and proteomics screening solutions through untargeted analysis and proprietary computational methods. Panome Bio was founded in 2022 and is headquartered in Saint Louis, Missouri.

2025年2月25日 · Panome Bio leverages metabolomics, proteomics, and multi-omic integration workflows to help biopharma discover novel biology, unravel mechanistic insights, and optimize biological systems.

Developer of metabolomics technologies designed to facilitate biomarker discovery and metabolite profiling.

2023年3月15日 · The Panome Bio platform uses advanced liquid chromatography – mass spectrometry assays and proprietary bioinformatic tools to gain actionable insights to metabolic pathways involved in cancer ...

Panome Bio is committed to making next generation functional phenotyping possible with Next-Generation Metabolomics and proteomics. We offer advanced methodology to create solutions for important biological questions